Table 2 Differences between patients with and without probable cognitive impairments in self-reported outcomes

Disease self-efficacy

6.06 (1.84)

5.08 (1.92)

6.35 (1.72)

 < .001**

0.72

Treatment self-efficacy

7.06 (1.62)

6.25 (1.68)

7.30 (1.52)

 < .001**

0.68

Skills and technique acquisition

2.79 (0.41)

2.63 (0.47)

2.84 (0.37)

.001**

0.52

Self-monitoring and insight

3.05 (0.38)

2.95 (0.40)

3.09 (0.37)

.011*

0.35

Health services navigation

2.98 (0.41)

2.86 (0.42)

3.02 (0.40)

.005**

0.39

Medication adherence

3.46 (0.76)

3.27 (0.75)

3.52 (0.76)

.018*

0.33

Renal adherence behaviour questionnaire

91.99 (11.94)

89.75 (11.88)

92.65 (11.91)

.074

0.24

 Fluid restrictions

38.53 (6.02)

37.66 (5.65)

38.79 (6.11)

.170

0.19

 Potassium/phosphate restrictions

19.94 (2.87)

19.51 (3.19)

20.06 (2.76)

.192

0.19

 Self-care

6.90 (2.09)

6.87 (1.98)

6.90 (2.12)

.902

0.02

 Times of particular difficulty

19.00 (3.27)

18.16 (3.08)

19.25 (3.30)

.014*

0.34

 Sodium restrictions

7.58 (1.78)

7.54 (1.85)

7.59 (1.76)

.861

0.02

Depressive symptoms

8.32 (4.17)

11.04 (3.82)

7.51 (3.92)

 < .001**

0.91

Anxious symptoms

7.10 (4.52)

10.31 (4.50)

6.13 (4.07)

 < .001**

1.00